Real-world outcomes in patients (pts) with metastatic triple-negative breast cancer (mTNBC) treated with sacituzumab govitecan (SG) in 2L+ in the United States (US)

2023
Kalinsky K, Spring L, Yam C, Taylor A, Sjekloca N, Kaushiva A, Lai C, Ntalla I, Nanda R
Read more